Publication | Closed Access

Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors

UrologyGenitourinary CancerMedicinePharmacologyPharmacotherapyCancer TreatmentOncologyCancer Growth